Elon Musk’s Ketamine use ruled off-limits in OpenAI trial
Synopsis
Elon Musk OpenAI fraud trial will move ahead without questions about Musk’s alleged ketamine use after a U.S. federal judge ruled the issue irrelevant to the lawsuit. The case focuses on Musk’s claim that OpenAI changed its nonprofit mission after securing major corporate funding.
Elon Musk OpenAI fraud trial will proceed without references to Musk’s alleged ketamine use after a federal judge ruled the issue irrelevant. The case focuses on claims about OpenAI’s structure and mission.
Key Highlights
- Elon Musk OpenAI fraud trial will proceed without questions about Musk’s alleged ketamine use.
- Federal judge ruled the topic is unrelated to the fraud claims before the court.
- Musk alleges OpenAI shifted from nonprofit goals toward a commercial structure.
- Global artificial-intelligence investment reached about $202 billion in 2025.
Elon Musk OpenAI fraud trial proceedings will move forward without references to the billionaire’s alleged ketamine use after a U.S. federal judge ruled the issue is not relevant to the case.
U.S. District Judge Yvonne Gonzalez Rogers issued the decision in Oakland, California, saying questions about alleged drug use could distract from the central legal dispute. The ruling limits what attorneys can present to the jury when the Elon Musk OpenAI fraud trial begins.
Elon Musk filed the lawsuit against OpenAI and its chief executive, Sam Altman. Musk claims the company moved away from commitments tied to its early nonprofit structure.
Court narrows evidence before trial
The Elon Musk OpenAI fraud trial centres on whether OpenAI misled Musk about the organisation’s purpose when it was founded in 2015. Musk was an early supporter and provided financial backing during the company’s early development.
In his lawsuit, Musk argues OpenAI later shifted toward a commercial model while maintaining access to the technology and resources built during its nonprofit phase.
Judge Gonzalez Rogers ruled that introducing allegations about ketamine use could prejudice the jury and does not directly relate to the fraud claims. As a result, the topic cannot be raised during the Elon Musk OpenAI fraud trial.
Dispute tied to OpenAI’s funding model
OpenAI has rejected Musk’s claims and said the lawsuit lacks merit. The company argues its structure evolved to secure funding needed to build large artificial-intelligence systems.
The Elon Musk OpenAI fraud trial unfolds as investment in artificial intelligence continues to rise globally. According to Crunchbase, AI companies attracted about $202 billion in funding in 2025, representing a major share of global venture investment.
Microsoft has committed about $13 billion in funding and cloud infrastructure to OpenAI. The partnership supports the development and operation of large AI models.
Global competition around AI development
Artificial intelligence development is concentrated in a few major regions. The United States leads in AI company funding and research activity, followed by China and European countries, according to multiple industry reports.
These regions host most large-scale AI computing infrastructure and technology companies. The Elon Musk OpenAI fraud trial is taking place as governments and corporations compete to expand AI development and deployment.
The case will now proceed to trial, where a jury will review claims about OpenAI’s structure, funding arrangements, and Musk’s early involvement.
FAQs
Q1. Why did the judge block questions about Elon Musk’s ketamine use?
The court ruled the issue is unrelated to the fraud claims being considered in the OpenAI lawsuit.
Q2. What is Elon Musk accusing OpenAI of?
Musk claims OpenAI misled him about its nonprofit mission and later shifted toward a commercial structure.
Q3. How much has Microsoft invested in OpenAI?
Microsoft has committed about $13 billion through funding agreements and cloud partnerships with OpenAI.
Follow Inspirepreneur Magazine for the business news.
Pooja Malik is a business journalist with over six years of experience covering startups, entrepreneurship, and emerging trends. She has previously worked with leading media platforms such as YourStory Media and BW BusinessWorld, where she reported on business, policy, and market developments. Currently, she serves as Editor at The Inspirepreneur Magazine, where she writes and edits stories across business, lifestyle, and travel, with a focus on clarity, accuracy, and reader relevance.
You Might Also Like
Nick Molnar: Pioneering the ‘Buy Now, Pay Later’ Revolution
Reserve Bank of Australia Keeps Interest Rate at 3.85%, Surprises Markets
